rs35998713
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_012082.4(ZFPM2):c.2385C>G(p.Val795Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0296 in 1,613,404 control chromosomes in the GnomAD database, including 1,348 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.055 ( 455 hom., cov: 32)
Exomes 𝑓: 0.027 ( 893 hom. )
Consequence
ZFPM2
NM_012082.4 synonymous
NM_012082.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.13
Publications
6 publications found
Genes affected
ZFPM2 (HGNC:16700): (zinc finger protein, FOG family member 2) The zinc finger protein encoded by this gene is a widely expressed member of the FOG family of transcription factors. The family members modulate the activity of GATA family proteins, which are important regulators of hematopoiesis and cardiogenesis in mammals. It has been demonstrated that the protein can both activate and down-regulate expression of GATA-target genes, suggesting different modulation in different promoter contexts. A related mRNA suggests an alternatively spliced product but this information is not yet fully supported by the sequence. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 8-105802467-C-G is Benign according to our data. Variant chr8-105802467-C-G is described in ClinVar as Benign. ClinVar VariationId is 260175.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.132 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ZFPM2 | NM_012082.4 | c.2385C>G | p.Val795Val | synonymous_variant | Exon 8 of 8 | ENST00000407775.7 | NP_036214.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ZFPM2 | ENST00000407775.7 | c.2385C>G | p.Val795Val | synonymous_variant | Exon 8 of 8 | 1 | NM_012082.4 | ENSP00000384179.2 |
Frequencies
GnomAD3 genomes AF: 0.0553 AC: 8409AN: 152140Hom.: 450 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
8409
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0311 AC: 7681AN: 247142 AF XY: 0.0291 show subpopulations
GnomAD2 exomes
AF:
AC:
7681
AN:
247142
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0269 AC: 39312AN: 1461146Hom.: 893 Cov.: 32 AF XY: 0.0265 AC XY: 19275AN XY: 726768 show subpopulations
GnomAD4 exome
AF:
AC:
39312
AN:
1461146
Hom.:
Cov.:
32
AF XY:
AC XY:
19275
AN XY:
726768
show subpopulations
African (AFR)
AF:
AC:
4737
AN:
33468
American (AMR)
AF:
AC:
1474
AN:
44616
Ashkenazi Jewish (ASJ)
AF:
AC:
1834
AN:
26106
East Asian (EAS)
AF:
AC:
181
AN:
39664
South Asian (SAS)
AF:
AC:
2478
AN:
86182
European-Finnish (FIN)
AF:
AC:
291
AN:
53338
Middle Eastern (MID)
AF:
AC:
188
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
25909
AN:
1111648
Other (OTH)
AF:
AC:
2220
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
2690
5380
8071
10761
13451
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1110
2220
3330
4440
5550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0554 AC: 8439AN: 152258Hom.: 455 Cov.: 32 AF XY: 0.0538 AC XY: 4006AN XY: 74456 show subpopulations
GnomAD4 genome
AF:
AC:
8439
AN:
152258
Hom.:
Cov.:
32
AF XY:
AC XY:
4006
AN XY:
74456
show subpopulations
African (AFR)
AF:
AC:
5609
AN:
41538
American (AMR)
AF:
AC:
798
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
238
AN:
3472
East Asian (EAS)
AF:
AC:
40
AN:
5172
South Asian (SAS)
AF:
AC:
134
AN:
4820
European-Finnish (FIN)
AF:
AC:
46
AN:
10620
Middle Eastern (MID)
AF:
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1433
AN:
68034
Other (OTH)
AF:
AC:
129
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
389
777
1166
1554
1943
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
188
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Jul 03, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Aug 09, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
46,XY sex reversal 9 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.